Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
High SUV uptake on FDG–PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG–PET/CT staging in lymphoma
Annals of Oncology, 06/02/09
Ngeow JYY et al. - In a trial to compare the value of positron emission tomography (PET)/computed tomography (CT) over conventional CT and bone marrow biopsy (BMB) in the initial evaluation of pts with lymphoma, it was found that PET/CT upstages 17% of cases and detects occult splenic involvement. This may have potential therapeutic and prognostic implications. SUV >10 may predict for an aggressive histology. Except for indolent B-NHL, data show that PET scans have a good overall negative predictive value (NPV) in excluding lymphomatous bone marrow involvement. This is particularly true of early-stage Hodgkin’s lymphoma (HL), suggesting that BMB may be safely omitted in this group.
Methods- Data on 122 pts with PET/CT scans as part of their initial staging were prospectively collected and reviewed.
- All pts had complete staging, including BMB.
- Among the 122 pts, 101 had NHL and 21 had HL.
- Compared with conventional CT, PET/CT upstaged 21 (17%) cases [B-cell NHL (B-NHL), 12; T-cell NHL (T-NHL), 3; HL, 6].
- In 13 pts with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG)-avid splenic lesions, 4 had normal CT findings.
- A maximum FDG uptake of >10 standardized uptake value (SUV) seems to significantly correlate with an aggressive B-cell lineage.
- PET scan was concordant with BMB results in 108 (89%) and discordant in 14 (11%) cases.
- In HL, these data show that PET scan and marrow results agreed in 19 of the cases (90%), being concordantly negative in 18 cases and concordantly positive in 1, giving a negative predictive value (NPV) of 100%, sensitivity of 100% and specificity of 90%.
- Of note, all 13 with early-stage HL had negative PET/CT scan and BMB.
- In NHL, all 17 cases of T-NHL had concordant PET and BMB results.
- In pts with aggressive B-NHL, BMB and PET/CT agreed in 58 pts (92%) and disagreed in 5 (8%), while corresponding rates in indolent B-cell lymphoma were 14 (67%) and 7 pts (33%), respectively.
- All 7 were falsely negative.
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Serum calcium levels are elevated among women with untreated postmenopausal breast cancer
Cancer Causes and Control, 11/03/09
Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents
Annals of Oncology, 11/02/09
Evaluating the combined effect of comorbidity and prostate-specific antigen kinetics on the risk of death in men after prostate-specific antigen recurrence
Journal of Clinical Oncology, 11/02/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


